4/1
03:42 pm
uthr
United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win [Seeking Alpha]
Low
Report
United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win [Seeking Alpha]
3/31
11:27 am
uthr
United Therapeutics (UTHR) had its price target raised by HC Wainwright from $600.00 to $660.00. They now have a "buy" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by HC Wainwright from $600.00 to $660.00. They now have a "buy" rating on the stock.
3/31
10:20 am
uthr
United Therapeutics (UTHR) had its price target raised by Wells Fargo & Company from $486.00 to $575.00. They now have an "equal weight" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by Wells Fargo & Company from $486.00 to $575.00. They now have an "equal weight" rating on the stock.
3/31
09:38 am
uthr
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo [Yahoo! Finance]
Medium
Report
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo [Yahoo! Finance]
3/31
09:02 am
uthr
United Therapeutics (UTHR) had its price target raised by Bank of America Corporation from $569.00 to $626.00. They now have a "neutral" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by Bank of America Corporation from $569.00 to $626.00. They now have a "neutral" rating on the stock.
3/30
06:03 pm
uthr
Why United Therapeutics (UTHR) Stock Is Up Today [Yahoo! Finance]
Low
Report
Why United Therapeutics (UTHR) Stock Is Up Today [Yahoo! Finance]
3/30
02:37 pm
uthr
United Therapeutics Stock Soars on Strong Phase 3 Lung Disease Results [Yahoo! Finance]
Low
Report
United Therapeutics Stock Soars on Strong Phase 3 Lung Disease Results [Yahoo! Finance]
3/30
11:52 am
uthr
United Therapeutics shares surge after positive IPF trial results [Yahoo! Finance]
Low
Report
United Therapeutics shares surge after positive IPF trial results [Yahoo! Finance]
3/30
09:49 am
uthr
United Therapeutics (UTHR) had its price target raised by TD Cowen from $575.00 to $660.00. They now have a "buy" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by TD Cowen from $575.00 to $660.00. They now have a "buy" rating on the stock.
3/30
07:33 am
uthr
S&P 500 Futures Climb in Premarket Trading; United Therapeutics, Alcoa Lead [Barron's]
Low
Report
S&P 500 Futures Climb in Premarket Trading; United Therapeutics, Alcoa Lead [Barron's]
3/30
07:15 am
uthr
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2 [Yahoo! Finance]
Low
Report
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2 [Yahoo! Finance]
3/30
07:00 am
uthr
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2
High
Report
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2
3/28
03:43 am
uthr
Cantor Fitzgerald Raises United Therapeutics (UTHR) Price Target to $625 [Yahoo! Finance]
Medium
Report
Cantor Fitzgerald Raises United Therapeutics (UTHR) Price Target to $625 [Yahoo! Finance]
3/27
08:05 pm
uthr
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Medium
Report
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
3/26
07:32 am
uthr
Liquidia: Yutrepia Has Impressed, But Here's Why I Remain Cautious (Rating Upgrade) [Seeking Alpha]
Low
Report
Liquidia: Yutrepia Has Impressed, But Here's Why I Remain Cautious (Rating Upgrade) [Seeking Alpha]
3/24
08:26 am
uthr
Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers [Yahoo! Finance]
Low
Report
Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers [Yahoo! Finance]
3/23
09:49 am
uthr
United Therapeutics (UTHR) had its price target raised by Wells Fargo & Company from $466.00 to $486.00. They now have an "equal weight" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by Wells Fargo & Company from $466.00 to $486.00. They now have an "equal weight" rating on the stock.
3/18
03:34 pm
uthr
1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm [Yahoo! Finance]
Low
Report
1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm [Yahoo! Finance]
3/14
01:26 pm
uthr
Tyvaso IPF Data In NEJM Reframes United Therapeutics Growth Potential [Yahoo! Finance]
Low
Report
Tyvaso IPF Data In NEJM Reframes United Therapeutics Growth Potential [Yahoo! Finance]
3/14
06:38 am
uthr
What Moved Markets This Week [Seeking Alpha]
Low
Report
What Moved Markets This Week [Seeking Alpha]
3/12
10:59 am
uthr
United Therapeutics (UTHR) had its price target raised by Cantor Fitzgerald from $525.00 to $625.00. They now have an "overweight" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by Cantor Fitzgerald from $525.00 to $625.00. They now have an "overweight" rating on the stock.
3/12
08:42 am
uthr
Asylon Robotics Announces New Advisors, Additions to Leadership Team [Yahoo! Finance]
Low
Report
Asylon Robotics Announces New Advisors, Additions to Leadership Team [Yahoo! Finance]
3/11
07:30 pm
uthr
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine [Yahoo! Finance]
Low
Report
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine [Yahoo! Finance]
3/11
06:14 pm
uthr
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
Low
Report
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
3/11
06:57 am
uthr
United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade) [Seeking Alpha]
Low
Report
United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade) [Seeking Alpha]